These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 15988011)
41. Noncanonical function of MEKK2 and MEK5 PB1 domains for coordinated extracellular signal-regulated kinase 5 and c-Jun N-terminal kinase signaling. Nakamura K; Johnson GL Mol Cell Biol; 2007 Jun; 27(12):4566-77. PubMed ID: 17452462 [TBL] [Abstract][Full Text] [Related]
42. Mechanical force induces type I collagen expression in human periodontal ligament fibroblasts through activation of ERK/JNK and AP-1. Kook SH; Hwang JM; Park JS; Kim EM; Heo JS; Jeon YM; Lee JC J Cell Biochem; 2009 Apr; 106(6):1060-7. PubMed ID: 19206162 [TBL] [Abstract][Full Text] [Related]
43. Humulone inhibits phorbol ester-induced COX-2 expression in mouse skin by blocking activation of NF-kappaB and AP-1: IkappaB kinase and c-Jun-N-terminal kinase as respective potential upstream targets. Lee JC; Kundu JK; Hwang DM; Na HK; Surh YJ Carcinogenesis; 2007 Jul; 28(7):1491-8. PubMed ID: 17372274 [TBL] [Abstract][Full Text] [Related]
44. Transient activation of NF-kappaB through a TAK1/IKK kinase pathway by TGF-beta1 inhibits AP-1/SMAD signaling and apoptosis: implications in liver tumor formation. Arsura M; Panta GR; Bilyeu JD; Cavin LG; Sovak MA; Oliver AA; Factor V; Heuchel R; Mercurio F; Thorgeirsson SS; Sonenshein GE Oncogene; 2003 Jan; 22(3):412-25. PubMed ID: 12545162 [TBL] [Abstract][Full Text] [Related]
45. IL-17R activation of human periodontal ligament fibroblasts induces IL-23 p19 production: Differential involvement of NF-κB versus JNK/AP-1 pathways. Zhu L; Wu Y; Wei H; Xing X; Zhan N; Xiong H; Peng B Mol Immunol; 2011 Jan; 48(4):647-56. PubMed ID: 21145111 [TBL] [Abstract][Full Text] [Related]
48. MEKK2 regulates focal adhesion stability and motility in invasive breast cancer cells. Mirza AA; Kahle MP; Ameka M; Campbell EM; Cuevas BD Biochim Biophys Acta; 2014 May; 1843(5):945-54. PubMed ID: 24491810 [TBL] [Abstract][Full Text] [Related]
49. MEKK2 regulates paxillin ubiquitylation and localization in MDA-MB 231 breast cancer cells. Ameka M; Kahle MP; Perez-Neut M; Gentile S; Mirza AA; Cuevas BD Biochem J; 2014 Nov; 464(1):99-108. PubMed ID: 25190348 [TBL] [Abstract][Full Text] [Related]
50. Homogeneous time-resolved fluorescence resonance energy transfer assay for measurement of Phox/Bem1p (PB1) domain heterodimerization. Nakamura K; Zawistowski JS; Hughes MA; Sexton JZ; Yeh LA; Johnson GL; Scott JE J Biomol Screen; 2008 Jun; 13(5):396-405. PubMed ID: 18480472 [TBL] [Abstract][Full Text] [Related]
51. In vitro activity of MEKK2 and MEKK3 in detergents is a function of a valine to serine difference in the catalytic domain. Widmann C; Sather S; Oyer R; Johnson GL; Dreskin SC Biochim Biophys Acta; 2001 May; 1547(1):167-73. PubMed ID: 11343802 [TBL] [Abstract][Full Text] [Related]
53. Identification and analysis of a novel dimerization domain shared by various members of c-Jun N-terminal kinase (JNK) scaffold proteins. Cohen-Katsenelson K; Wasserman T; Darlyuk-Saadon I; Rabner A; Glaser F; Aronheim A J Biol Chem; 2013 Mar; 288(10):7294-304. PubMed ID: 23341463 [TBL] [Abstract][Full Text] [Related]
54. Discovery and characterization of an iminocoumarin scaffold as an inhibitor of MEKK2 (MAP3K2). Ahmad S; St Hilaire VR; Dandepally SR; Johnson GL; Williams AL; Scott JE Biochem Biophys Res Commun; 2018 Jan; 496(1):205-211. PubMed ID: 29309787 [TBL] [Abstract][Full Text] [Related]
55. Decrease in MAP3Ks expression enhances the cell death caused by hyperthermia. Enomoto A; Fukasawa T; Terunuma H; Nakagawa K; Yoshizaki A; Sato S; Miyagawa K Int J Hyperthermia; 2022; 39(1):200-208. PubMed ID: 35042442 [TBL] [Abstract][Full Text] [Related]
56. Bestrophin3 Deficiency in Vascular Smooth Muscle Cells Activates MEKK2/3-MAPK Signaling to Trigger Spontaneous Aortic Dissection. Zhang TT; Lei QQ; He J; Guan X; Zhang X; Huang Y; Zhou ZY; Fan RX; Wang T; Li CX; Shang JY; Lin ZM; Peng WL; Xia LK; He YL; Hong CY; Ou JS; Pang RP; Fan XP; Huang H; Zhou JG Circulation; 2023 Aug; 148(7):589-606. PubMed ID: 37203562 [TBL] [Abstract][Full Text] [Related]
57. Overexpression of MEKK2 is associated with colorectal carcinogenesis. Jiang L; Huang M; Wang L; Fan X; Wang P; Wang D; Fu X; Wang J Oncol Lett; 2013 Nov; 6(5):1333-1337. PubMed ID: 24179519 [TBL] [Abstract][Full Text] [Related]
58. Identification of ponatinib and other known kinase inhibitors with potent MEKK2 inhibitory activity. Ahmad S; Johnson GL; Scott JE Biochem Biophys Res Commun; 2015 Aug; 463(4):888-93. PubMed ID: 26056008 [TBL] [Abstract][Full Text] [Related]
59. BEST3-Mediated MEKK2/3 Activation: A Novel Therapeutic Target in Aortopathies. Sawada H; Daugherty A Circulation; 2023 Aug; 148(7):607-609. PubMed ID: 37579014 [No Abstract] [Full Text] [Related]
60. The mTORC2 signaling network: targets and cross-talks. Ragupathi A; Kim C; Jacinto E Biochem J; 2024 Jan; 481(2):45-91. PubMed ID: 38270460 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]